12,552 Shares in Azenta, Inc. (NASDAQ:AZTA) Purchased by Petrus Trust Company LTA

Petrus Trust Company LTA bought a new position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 12,552 shares of the company's stock, valued at approximately $608,000.

Other hedge funds have also added to or reduced their stakes in the company. Hantz Financial Services Inc. acquired a new position in shares of Azenta during the 2nd quarter valued at $30,000. Farther Finance Advisors LLC boosted its holdings in shares of Azenta by 20.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock worth $74,000 after buying an additional 256 shares during the last quarter. Benjamin F. Edwards & Company Inc. boosted its holdings in shares of Azenta by 150.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company's stock worth $84,000 after buying an additional 955 shares during the last quarter. Net Worth Advisory Group bought a new position in Azenta during the third quarter worth about $205,000. Finally, Sanctuary Advisors LLC bought a new position in Azenta during the second quarter worth about $222,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Azenta

In other Azenta news, CEO John Marotta bought 12,717 shares of the company's stock in a transaction dated Monday, November 18th. The shares were purchased at an average price of $39.48 per share, for a total transaction of $502,067.16. Following the acquisition, the chief executive officer now owns 99,612 shares in the company, valued at approximately $3,932,681.76. This represents a 14.63 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director William L. Cornog bought 12,500 shares of the company's stock in a transaction dated Monday, November 18th. The shares were acquired at an average price of $39.60 per share, for a total transaction of $495,000.00. Following the acquisition, the director now owns 14,755 shares in the company, valued at approximately $584,298. This represents a 554.32 % increase in their position. The disclosure for this purchase can be found here. Insiders have sold a total of 3,018 shares of company stock worth $126,689 over the last quarter. Corporate insiders own 1.77% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on AZTA shares. Evercore ISI cut their price objective on shares of Azenta from $53.00 to $50.00 and set an "in-line" rating for the company in a research report on Tuesday, October 1st. Needham & Company LLC decreased their price target on shares of Azenta from $69.00 to $55.00 and set a "buy" rating on the stock in a research note on Wednesday, November 13th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $63.60.

Azenta Stock Performance

Shares of NASDAQ AZTA traded down $1.93 during mid-day trading on Thursday, hitting $45.00. The stock had a trading volume of 784,441 shares, compared to its average volume of 561,822. Azenta, Inc. has a 1 year low of $38.82 and a 1 year high of $69.16. The business has a 50 day moving average price of $44.88 and a two-hundred day moving average price of $49.79. The firm has a market cap of $2.05 billion, a P/E ratio of -15.80 and a beta of 1.49.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.10 by $0.08. The company had revenue of $170.00 million for the quarter, compared to the consensus estimate of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The firm's revenue for the quarter was down 1.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.13 earnings per share. Equities research analysts predict that Azenta, Inc. will post 0.4 EPS for the current fiscal year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.